Suchergebnisse - "Ericsson, Åsa"

PubPharm (57)

1

The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden : Looking beyond health costs

enthalten in: Diabetes, obesity & metabolism | 2022

von Kotsopoulos, N. | Connolly, M. | Willis, M. | +3

2

Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting

enthalten in: PharmacoEconomics - open | 2022

von Eliasson, B. | Ericsson, �. | Fridhammar, A. | +3

3

Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting

enthalten in: PharmacoEconomics - open | 2022

von Eliasson, B. | Ericsson, �. | Fridhammar, A. | +3

4

Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting

enthalten in: PharmacoEconomics - open | 2022

von Eliasson, B. | Ericsson, �. | Fridhammar, A. | +3

5

Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting

enthalten in: PharmacoEconomics - open | 2022

von Eliasson, B. | Ericsson, �. | Fridhammar, A. | +3

6

The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden : Looking beyond health costs

enthalten in: Diabetes, Obesity and Metabolism | 2022

von Kotsopoulos, N. | Connolly, M. | Willis, M. | +3

7

The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden : A health economic modelling analysis based on nationwide data

enthalten in: Diabetes, obesity & metabolism | 2021

von Hellgren, M. | Svensson, A. | Franzén, S. | +6

8

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden : A Cost-Effectiveness Analysis

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2021

von Jendle, J. | Ericsson, �. | Gundgaard, J. | +3

9

Costs of diabetes complications : hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden

enthalten in: Diabetologia | 2020

von Andersson, E. | Persson, S. | Hallén, N. | +5

10

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

enthalten in: Diabetes therapy | 2020

von Jendle, J. | Ericsson, �. | Gundgaard, J. | +3

1
2
3
4
5
6
Nächster »
[6]